Barclays Initiates Coverage of Cellectis S.A. - Depositary Receipt (CLLS) with Overweight Recommendation

Fintel reports that on May 28, 2026, Barclays initiated coverage of Cellectis S.A. - Depositary Receipt (NasdaqGM:CLLS) with a Overweight recommendation. Analyst Price Forecast Suggests 110.62% Upside https://www.nasdaq.com/articles/barclays-initiates-coverage-cellectis-sa-depositary-receipt-clls-overweight-recommendation